Research & Clinical Trials – Page 11
-
newsResearch & Clinical TrialsDr. Nagla Abdel Karim of the Georgia Cancer Center has seen the effectiveness of cabozantinib with certain types of thyroid, kidney and liver cancers.
-
newsResearch & Clinical Trials
COVID-19 Pandemic Delays Mesothelioma Clinical Trials
Medical centers across the country have slowed or stopped the enrollment of new patients in mesothelioma clinical trials because of the all-consuming COVID-19… -
newsResearch & Clinical Trials
Promising Data Supports Curcumin Treatment for Mesothelioma
The plant-based substance curcumin could soon be included in the multidisciplinary treatment of malignant mesothelioma, according to a recent multicenter, international study review. Curcumin,… -
newsResearch & Clinical Trials
UPenn Research with Mesothelioma Blood Test Shows Promise
Scientist Ian Blair at the University of Pennsylvania School of Medicine believes his team is close to identifying the variant of a blood-based biomarker… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial Testing New INBRX-109 Antibody
A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at… -
newsResearch & Clinical Trials
Study to Clarify Radiation Benefits in Mesothelioma Patients
An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will… -
newsResearch & Clinical Trials
Mesothelioma Gene Therapy Trial Shows ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase… -
newsResearch & Clinical Trials
Duke Completes Largest Study of Mesothelioma in Women
Women diagnosed with peritoneal mesothelioma were 10 years younger on average than those with pleural mesothelioma in a recent case study at the Duke… -
newsResearch & Clinical Trials
ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results…